Latest News in the pharma Industry

Top Stories

EMA Reviews Cardiovascular Risk of Multaq

EMA Reviews Cardiovascular Risk of Multaq

12 Jul 2011

The European Medicines Agency is reviewing the cardiovascular risk of the anti-arrhythmic medicine Multaq.

Read more 
Teva and Merck Settle Cholesterol Drugs Dispute

Teva and Merck Settle Cholesterol Drugs Dispute

12 Jul 2011

Teva has reached a compromise with Merck and will not sell cholesterol drugs Vytorin and Zetia until 2017.

Read more 
Novo Nordisk with CWD to Distribute Diabetes Management Kits

Novo Nordisk with CWD to Distribute Diabetes Management Kits

11 Jul 2011

Novo Nordisk and the advocacy organization Children with Diabetes, Inc will develop and distribute resources to help newly diagnosed children with type 1 diabetes adjust to their new lifestyle.

Read more 
South Africa Urges BMS to Prevent Aids Drug Shortage

South Africa Urges BMS to Prevent Aids Drug Shortage

11 Jul 2011

Bristol-Myers Squibb is the only company that has registered the drug Amphotericin B in South Africa to treat the AIDS defining-disease cryptococcal meningitis.

Read more 
Indian Pharma Firms Filed 90 DMFs in Q1

Indian Pharma Firms Filed 90 DMFs in Q1

8 Jul 2011

During the first quarter of 2011, Indian pharma companies filed 90 DMFs as compared to 75 and 91 DMFs respectively during first quarter of 2010 and 2009.

Read more 
Unilabs & Biogen Ink Pact for Antibody Assay Test

Unilabs & Biogen Ink Pact for Antibody Assay Test

7 Jul 2011

Biogen Idec has selected Unilabs to provide a companion diagnostic anti-JCV antibody assay test.

Read more 
Malaysia Attracts Global Partners to Boost Biotechnology Industry

Malaysia Attracts Global Partners to Boost Biotechnology Industry

7 Jul 2011

Malaysian Biotechnology Corporation is boosting Malaysia’s biotechnology industry through a series of agreements and collaborations.

Read more 
BMS and Innate Pharma Announce Global License Agreement

BMS and Innate Pharma Announce Global License Agreement

7 Jul 2011

Under the terms of the agreement, Bristol-Myers Squibb will fund the development of IPH2102, make an upfront payment of $35 million and additional payments of up to $430 million.

Read more 
Growing Prevalence of Diabetes to Grow Sales of Insulin Delivery Systems

Growing Prevalence of Diabetes to Grow Sales of Insulin Delivery Systems

7 Jul 2011

A new report says the growing prevalence of type 1 and type 2 diabetes is ensuring rapid growth for insulin management systems.

Read more 
Indian Drugmakers Eye US Market after FDA Inspections

Indian Drugmakers Eye US Market after FDA Inspections

6 Jul 2011

The FDA inspections in the last few weeks are raising hopes among some of Indian companies they will shortly be able to export medicines to the world’s largest drug market.

Read more 
Developing Countries Warn against Unethical Drug Trials

Developing Countries Warn against Unethical Drug Trials

6 Jul 2011

A recent gathering of science journalists in Qatar was treated to a look at the dark side of trend.

Read more 
GSK Signs Agreement to Fight against Doping in Sport

GSK Signs Agreement to Fight against Doping in Sport

6 Jul 2011

GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency to help detect emerging performance-enhance drugs in sport.

Read more